The Pfizer-BioNTech vaccine is recommended for people aged 16 years and older.
More
As countries in Europe struggle with shortages of COVID-19 vaccines, China has stepped up its efforts in the Western Balkans, supplying injections and collecting diplomatic wins in the region.
More
COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, today announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine candidate, which has already received WHO emergency use listing. Rollout will commence with the
More
Serbia launched on December 24 its coronavirus vaccination program using the Pfizer-BioNTech shot.
More